Loading…
99,167 grants found
Showing 3,941 – 3,960 of 99,167 grants
PROJECT SUMMARY/ABSTRACT Multiple myeloma is the second most common hematologic cancer in the US and remains incurable, with virtually all patients developing relapsed or refractor...
OVERALL COMPONENT – PROJECT SUMMARY/ABSTRACT This revised application for a Program Project seeks support for a coordinated, multi-disciplinary investigation of molecular mechanism...
SUMMARY The Administrative Core is located within the administrative offices of the Blood Research Institute, the research arm of Versiti Blood Center of Wisconsin, and serves as t...
CORE B SUMMARY This Program Project focuses on a group of closely related and clinically important antibody-mediated thrombocytopenias in which β3 integrins (αIIbβ3, αVβ3, and sing...
ABSTRACT/SUMMARY Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT), is a non-malignant hematologic bleeding disorder that arises when maternal antibodies specific for fetal platel...
ABSTRACT Heparin-induced thrombocytopenia (HIT) is an immune reaction caused by antibodies (Abs) that target platelet factor 4 (PF4) when bound to heparin (H) or other glycosaminog...
ABSTRACT Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a complication of adenoviral (AdV)-based COVID-19 vaccination. Antibodies (Abs) against the 70-aa chemokine, p...
ABSTRACT Chronic ocular surface pain (COSP) affects approximately 5-15% of the US population at some time in their lives at an estimated cost of over $55 billion annually. People w...
PROJECT SUMMARY/ABSTRACT: Venous thromboembolism (VTE) is a major cause of morbidity and mortality. VTE is caused by acquired and genetic factors, but the genetic factors that modi...
PROJECT SUMMARY Cystic fibrosis (CF) is a debilitating genetic disorder that predominantly impacts the lungs and pancreas due to mutations in the cystic fibrosis transmembrane cond...
Project Summary CAR T cell therapies have been revolutionary for patients with relapsed/refractory hematologic malignancies; however, the relapse rates are unacceptably high, with...
PROJECT SUMMARY Secondary lymphedema poses a significant financial and health burden afflicting 1 in 1000 Americans, resulting in a debilitating and incurable swelling and fibrosis...
PROJECT SUMMARY/ABSTRACT Heart failure with preserved ejection fraction (HFpEF), a syndrome characterized by exercise intolerance due to breathlessness and fatigue, is a major publ...
Oral anticancer medications (OAM) are becoming standard of care for growing numbers of patients. Multiple myeloma (MM), chronic myeloid leukemia (CML), and chronic lymphocytic leuk...
PROJECT SUMMARY/ABSTRACT A transparent cornea that maintains its architecture and refracts light is essential for visual acuity. Despite advances in corneal wound healing, individu...
ABSTRACT Infections with Treponema pallidum, the causative agent of syphilis, have been rapidly rising in the United States over the past decade and present an increasing threat to...
PROJECT SUMMARY The overarching objective of this new R01 grant proposal is to perform preclinical drug development studies to create potent, selective, metabolically stable, and p...
PROJECT SUMMARY The intricate orchestration of genetic and epigenetic dynamics in neurobiological systems plays a central role in substance use disorders (SUDs), with cocaine use c...
Project Summary More than 90% of cancer mortalities are associated with metastasis. Despite advances in cancer therapies, there has not been significant progress in metastasis-asso...
PROJECT SUMMARY Sudden cardiac death due to ventricular arrhythmias (VAs) is a leading cause of mortality world-wide. Despite advancements in anti-arrhythmia therapies, VA rates re...